In a study conducted by Li et al., it was found that baseline serum Gal-3 levels exceeding 20.24 ng/mL could function as an independent predictor of all-cause mortality in patients with renal AL amyloidosis [4]. This evidence concerns the gene LGALS3 and AL amyloidosis.